BR9809171A - Processo de tratamento de uma matéria-prima láctica, contendo gmp - Google Patents

Processo de tratamento de uma matéria-prima láctica, contendo gmp

Info

Publication number
BR9809171A
BR9809171A BR9809171-9A BR9809171A BR9809171A BR 9809171 A BR9809171 A BR 9809171A BR 9809171 A BR9809171 A BR 9809171A BR 9809171 A BR9809171 A BR 9809171A
Authority
BR
Brazil
Prior art keywords
raw material
resin
material containing
treatment process
lactic raw
Prior art date
Application number
BR9809171-9A
Other languages
English (en)
Other versions
BR9809171B1 (pt
Inventor
Peter Erdmann
Fred Neumann
Original Assignee
Soc D Produites Nestle S A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Soc D Produites Nestle S A filed Critical Soc D Produites Nestle S A
Publication of BR9809171A publication Critical patent/BR9809171A/pt
Publication of BR9809171B1 publication Critical patent/BR9809171B1/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00—Milk preparations; Milk powder or milk powder preparations
    • A23C9/14—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment
    • A23C9/146—Milk preparations; Milk powder or milk powder preparations in which the chemical composition of the milk is modified by non-chemical treatment by ion-exchange
    • A23C9/1465—Chromatographic separation of protein or lactose fraction; Adsorption of protein or lactose fraction followed by elution
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J1/00—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites
    • A23J1/20—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey
    • A23J1/205—Obtaining protein compositions for foodstuffs; Bulk opening of eggs and separation of yolks from whites from milk, e.g. casein; from whey from whey, e.g. lactalbumine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Birds (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Zoology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Dairy Products (AREA)
  • Peptides Or Proteins (AREA)
  • Confectionery (AREA)
  • Cosmetics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Patente de Invenção: <B>"PROCESSO DE TRATAMENTO DE UMA MATéRIA-PRIMA LáCTICA, CONTENDO GMP"<D>. Um processo industrial simples de troca de íons consiste em tratar uma matéria-prima láctica líquida que contém o glicomacropeptídeo na presença de uma resina aniónica fraca, de modo a se obter um produto protéico melhorado, utilizável na alimentação, e esse glicomacropeptídeo, que é adsorvido seletivamente sobre a resina, depois é eluído dessa resina. Antes do tratamento com a resina, a matéria-prima líquida é descationizada, de modo que o pH tenha um valor de 1 a 4,5.
BRPI9809171-9A 1997-05-27 1998-05-22 processo de tratamento de uma matéria-prima láctica, contendo glicomacropeptìdeo ou caseinoglicomacropeptìdeo (''gmp''). BR9809171B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97201607A EP0880902A1 (fr) 1997-05-27 1997-05-27 Procédé de traitement d'une matiére première lactosérique
EP97201607.5 1997-05-27
PCT/EP1998/003176 WO1998053702A1 (fr) 1997-05-27 1998-05-22 Procede de traitement d'une matiere premiere lactique contenant du gmp

Publications (2)

Publication Number Publication Date
BR9809171A true BR9809171A (pt) 2000-08-01
BR9809171B1 BR9809171B1 (pt) 2011-01-11

Family

ID=8228378

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI9809171-9A BR9809171B1 (pt) 1997-05-27 1998-05-22 processo de tratamento de uma matéria-prima láctica, contendo glicomacropeptìdeo ou caseinoglicomacropeptìdeo (''gmp'').

Country Status (9)

Country Link
US (1) US6787158B1 (pt)
EP (2) EP0880902A1 (pt)
JP (1) JP4286325B2 (pt)
AU (1) AU746520B2 (pt)
BR (1) BR9809171B1 (pt)
CA (1) CA2288184C (pt)
DE (1) DE69836909T2 (pt)
NZ (1) NZ500848A (pt)
WO (1) WO1998053702A1 (pt)

Families Citing this family (63)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9923048D0 (en) * 1999-09-29 1999-12-01 Nestle Sa Composition comprising casein protein and whey protein
ATE303077T1 (de) * 1999-04-29 2005-09-15 Nestle Sa Süssmolkeprotein enthaltende säuglingsnahrung
US6777391B1 (en) 1999-04-29 2004-08-17 Nestec S.A. Composition for an infant formula having a low threonine content
EP1326499A1 (en) * 2000-10-10 2003-07-16 Bopa Ireland Limited A dairy product
AU2002345773A1 (en) * 2001-06-08 2002-12-23 Societe Des Produits Nestle S.A. Sugar-based composition containing caseinoglycomacropeptide
NZ544642A (en) * 2003-06-23 2009-01-31 Nestec Sa Infant or follow-on formula
US20070031537A1 (en) * 2003-06-23 2007-02-08 Marie-Cristene Secretin Infant or follow-on formula
CA2604338A1 (en) 2005-04-13 2006-10-19 Nestec S.A. Infant formula with probiotics
EP1870649A1 (en) * 2006-06-20 2007-12-26 Octapharma AG Lyophilisation targetting defined residual moisture by limited desorption energy levels
EP1932437A1 (en) 2006-12-15 2008-06-18 Nestec S.A. Infant formula
FI120953B (fi) * 2007-06-26 2010-05-31 Valio Oy Menetelmä hyvin säilyvän vähälaktoosisen tai laktoosittoman maitotuotteen valmistamiseksi
EP2044851A1 (en) 2007-09-26 2009-04-08 Nestec S.A. Prevention of allergy at weaning
US20110048219A1 (en) * 2007-11-13 2011-03-03 Pyles Robert A Blast-resistant barrier
WO2009068549A1 (en) 2007-11-26 2009-06-04 Nestec S.A. Age-tailored nutrition system for infants
EP2096115A1 (en) 2008-02-26 2009-09-02 Nestec S.A. Oligosaccharide ingredient
EP2116140A1 (en) * 2008-05-08 2009-11-11 Nestec S.A. Sialic acid to support the immune system in the elderly
BRPI0919718A2 (pt) * 2008-10-20 2015-08-18 Nestec Sa Composição nutricional com propriedades antirregurgitação
US9055752B2 (en) 2008-11-06 2015-06-16 Intercontinental Great Brands Llc Shelf-stable concentrated dairy liquids and methods of forming thereof
US8586077B2 (en) 2009-01-19 2013-11-19 Nestec S.A. Nutritional composition for infants
CA2755077A1 (en) 2009-04-01 2010-10-07 Nestec S.A. Reduction of risk of obesity
NZ595062A (en) 2009-04-02 2012-10-26 Novozymes As Process for making a milk-based protein hydrolysate
US8846612B2 (en) 2009-04-03 2014-09-30 Nestec S.A. Promotion of healthy catch-up growth
EP2251030A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and development in infants
EP2251031A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and neuronal health and development in the infant gut
EP2251029A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and gut neuronal health in adults and/or elderly
EP2251032A1 (en) 2009-05-12 2010-11-17 Nestec S.A. Lactoferrin and brain health and protection in adults
WO2011057336A1 (en) * 2009-11-11 2011-05-19 Oral Health Australia Pty Ltd Antibiofilm glycopeptides
RU2563355C2 (ru) 2009-12-08 2015-09-20 Нестек С.А. Смесь для грудных детей с пробиотиками и компонентами оболочек жировых шариков молока
WO2012004585A1 (en) * 2010-07-09 2012-01-12 Abdulla Badawy Ingestible formulation comprising glycomacropeptide and at least one of tryptophan, tyrosine and phenylalanine and uses thereof
UA112972C2 (uk) 2010-09-08 2016-11-25 Інтерконтінентал Грейт Брендс ЛЛС Рідкий молочний концентрат з високим вмістом сухих речовин
EP2436389A1 (en) 2010-10-01 2012-04-04 Nestec S.A. Milk-based protein hydrolysates and infant formulae and nutritional compositions made thereof
EP2717705A1 (en) 2011-06-08 2014-04-16 Nestec S.A. Nutritional compositions having exogenous milk fat globule membrane components
MX2014009230A (es) 2012-02-06 2015-05-15 Arla Foods Amba Producto de confiteria congelado bajo en proteinas.
MX2016001225A (es) 2013-09-02 2016-05-24 Nestec Sa Lactoferrina y memoria y velocidad de aprendizaje en niños.
RU2687038C1 (ru) 2013-11-29 2019-05-06 Нестек С.А. Соответствующие возрастным потребностям питательные композиции с различным содержанием белка
AU2014363470B2 (en) * 2013-12-13 2018-09-06 Société des Produits Nestlé S.A. Use of a modified sweet whey and a modified sweet whey containing infant formula for promoting the postnatal development of the infant central nervous system and related cognitive functions
ES2918577T3 (es) 2013-12-16 2022-07-19 Nestle Sa Péptidos recientemente identificados para uso en la inducción de tolerancia oral
EP3082473A2 (en) 2013-12-19 2016-10-26 Nestec S.A. Nutritional composition to reduce metabolic stress in infants
WO2016128254A1 (en) * 2015-02-09 2016-08-18 Nestec S.A. Process for treating a sweet whey material containing cgmp and related method for producing a protein material having a targeted tryptophan/threonine ratio
EP3256001B1 (en) * 2015-02-09 2023-08-09 Société des Produits Nestlé S.A. Process for treating sweet whey such as to obtain a protein material suitable for hypoallergenic infant formulae
WO2016156077A1 (en) 2015-03-30 2016-10-06 Nestec S.A. Milk-based protein hydrolysates and compositions made thereof
WO2016198630A1 (en) 2015-06-12 2016-12-15 Nestec S.A. Combination of tolerogenic peptides and tfg-b for use in the induction and maintenance of oral tolerance in young mammals
AU2016374161A1 (en) 2015-12-14 2018-04-19 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
BR112018011793A2 (pt) 2015-12-14 2018-12-04 Nestec Sa composições nutricionais e fórmulas para bebês para promover mielinização no cérebro
AU2016376167A1 (en) 2015-12-14 2018-04-26 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
EP4233907A3 (en) 2015-12-14 2024-01-10 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas to promote myelination in the brain
WO2017102721A1 (en) 2015-12-14 2017-06-22 Nestec S.A. Nutritional compositions and infant formulas to promote myelination in the brain
BR112018011366A2 (pt) 2016-03-30 2018-12-04 Nestec Sa composições que compreendem minerais e seu uso
MX2018008520A (es) 2016-03-30 2018-08-16 Nestec Sa Composiciones que comprenden acidos grasos y su uso.
WO2017167417A1 (en) 2016-03-30 2017-10-05 Nestec S.A. Compositions comprising choline and their use
WO2017167898A2 (en) 2016-03-30 2017-10-05 Nestec S.A. Compositions and their use
BR112018011404A2 (pt) 2016-03-30 2018-12-04 Nestec Sa composições que compreendem vitaminas e seu uso
MX2018008522A (es) 2016-03-30 2018-08-16 Nestec Sa Composiciones que comprenden fosfolipido y su uso.
WO2018149907A1 (en) 2017-02-20 2018-08-23 Nestec S.A. Nutritional compositions with partially hydrolysed proteins for use in inducing glucose and/or insulin response(s) close to the ones observed with human milk
WO2019092021A1 (en) 2017-11-09 2019-05-16 Nestec S.A. An array of age-tailored nutritional formula for infants and young children for use in the prevention of sub-optimal body composition
EP3740087B1 (en) 2018-01-16 2022-05-18 FrieslandCampina Nederland B.V. Hypoallergenic infant formula and methods for preparing the same
CN113226465A (zh) 2018-12-19 2021-08-06 雀巢产品有限公司 用于预防或减少经皮水分流失并改善皮肤屏障功能的组合物
US20240138460A1 (en) 2019-10-17 2024-05-02 Societe Des Produits Nestle S.A. Extensively hydrolysed infant formula
CA3153046A1 (en) 2019-10-17 2021-04-22 Societe Des Produits Nestle S.A. Infant formula
WO2021136751A1 (en) 2019-12-30 2021-07-08 Société des Produits Nestlé S.A. Infant formula
US20230381211A1 (en) 2020-10-16 2023-11-30 Societe Des Produits Nestle S.A. Nutritional composition comprising human milk oligosaccharides
US20240009216A1 (en) 2020-11-10 2024-01-11 Societe Des Produits Nestle S.A. Nutritional composition
CN117377391A (zh) 2021-04-19 2024-01-09 雀巢产品有限公司 乳蛋白质级分作为骨桥蛋白源的用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1442298A (en) * 1972-09-01 1976-07-14 Ici Ltd Replenishment of fluidised beds
GB2188526B (en) * 1986-02-19 1990-10-10 Agricultural & Food Res A proteinaceous material obtainable from milk or casein-containing milk products ,process for its production and its use in food and drink
JP2622686B2 (ja) 1987-05-15 1997-06-18 雪印乳業株式会社 ｋ−カゼイングリコマクロペプチドの製造法
FR2646775A1 (fr) 1989-05-11 1990-11-16 Centre Nat Rech Scient Utilisation du caseinoglycopeptide k, notamment de lait de vache, pour la fabrication d'une composition, notamment d'un medicament, pour la prevention et le traitement des thromboses
JP2961625B2 (ja) * 1991-01-21 1999-10-12 雪印乳業株式会社 α−ラクトアルブミン含有量の高い組成物の製造方法
JP2920427B2 (ja) * 1991-01-21 1999-07-19 雪印乳業株式会社 κ−カゼイングリコマクロペプチドの製造法
JP3035833B2 (ja) * 1991-01-21 2000-04-24 雪印乳業株式会社 シアル酸類含有組成物の製造方法
JP3123618B2 (ja) * 1992-03-18 2001-01-15 雪印乳業株式会社 新規ペプチド、該ペプチドを有効成分とする胃酸分泌抑制−抗潰瘍剤及び飲食品
JP3161846B2 (ja) * 1992-11-11 2001-04-25 明治乳業株式会社 牛乳ホエ−中のシアル酸結合ペプタイドの分離法
DE4344342C2 (de) * 1993-12-23 1996-08-08 Milupa Ag Molkenprotein-dominante Säuglingsnahrung
US6168823B1 (en) * 1997-10-09 2001-01-02 Wisconsin Alumni Research Foundation Production of substantially pure kappa casein macropeptide
US5968586A (en) * 1997-10-09 1999-10-19 Wisconsin Alumni Research Foundation Production of κ-casein macropeptide for nutraceutical uses

Also Published As

Publication number Publication date
EP0880902A1 (fr) 1998-12-02
DE69836909T2 (de) 2007-09-06
EP0986312A1 (fr) 2000-03-22
WO1998053702A1 (fr) 1998-12-03
AU746520B2 (en) 2002-05-02
DE69836909D1 (de) 2007-03-08
BR9809171B1 (pt) 2011-01-11
EP0986312B1 (fr) 2007-01-17
AU8107798A (en) 1998-12-30
JP4286325B2 (ja) 2009-06-24
CA2288184A1 (en) 1998-12-03
NZ500848A (en) 2001-12-21
JP2002514085A (ja) 2002-05-14
CA2288184C (en) 2009-10-27
US6787158B1 (en) 2004-09-07

Similar Documents

Publication Publication Date Title
BR9809171A (pt) Processo de tratamento de uma matéria-prima láctica, contendo gmp
BR0106649A (pt) Composição fertilizante contendo enxofre e processo para preparação da mesma
PT1133238E (pt) Processo de preapacao de uma composicao proteica e de uma formula infantil que a contem
DE69622701D1 (de) Hemmung von tau-tau-verknüpfung
EP0431129A4 (en) Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions
BR9404053A (pt) Composição para agricultura, processo para o tratamento de uma planta ou artrópode
NO20064863L (no) Fremgangsmate for behandling av vannstrommer som inneholder faste biologiske stoffer
DE69103775D1 (de) Vorrichtung zur Unterscheidung von stabilen und instabilen ventriculären tachycardien.
DE69534130D1 (de) Verbindungen zur behandlung von erkrankungen,die mit des vasculogenese und/oder angiogenese in verbunden stehen.
BR9814814A (pt) Processos para modular função de quinase de proteìna serina/treonina com compostos à base de 5-azaquinoxalina
DE69413051D1 (de) Waschmittelzusammensetzungen enthaltend mittel zur verhinderung des anlaufens von silber
BR0012983A (pt) Processo de tratamento por impregnação de um material arqutetural &#34;permeável&#34;, dispersão lìquida em fase essencialmente aquosa, utilização do processo ou da dispersão, e, material arquitetural &#34;permeável&#34;
BR9301552A (pt) Composicao desinfetante concentrada,composicao desinfetante aquosa e processo para desinfetar uma superficie ou um artigo
BR9808606A (pt) Materiais e métodos para tratamento de doenças com ribozimas
ITTO930547A0 (it) Procedimento e macchina per sterilizzare o disinfettare i rifiuti.
EP0700684A3 (de) Zusammensetzungen, enthaltend Prothrombinkomplex-Konzentrat und wenigstens eine weitere Komponente das die Blutgerrinnung fördert, als Gegenmittel für Blut-Anticoagulanzien
BR9911917A (pt) Composições compreendendo análogos de gaba e cafeìna
HK1041714A1 (en) A-beta-peptide screening assay
DE60204584D1 (de) Zusammensetzungen enthaltend eine niedrige konzentration an peroxide zur behandlung von vaginitis
EP0749312A4 (en) DIROFILARIA IMMITIS - Gp29 - PROTEINS, NUCLEIC ACID MOLECULES AND THEIR USE
ZA903334B (en) Cleansing composition
BR9811643A (pt) Suplementação quìmica de osso
BR9900606A (pt) Processo para controlar e destruir criaturas pequenas patogênicas, particularmente inseto e vermes.
BR9005763A (pt) Utilizacao de aminoacidos protegidos contra o ph do rumen na alimentacao do carneiro
EP1038524A4 (en) L-THREONATE IRON, PHARMACEUTICAL COMPOSITION AND USE FOR IMPROVEMENT AND TREATMENT OF ANEMIA IN PEOPLE

Legal Events

Date Code Title Description
B07A Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette]
B06A Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 11/01/2011, OBSERVADAS AS CONDICOES LEGAIS.

B15K Others concerning applications: alteration of classification

Ipc: A61Q 11/00 (2006.01), A23C 9/146 (2006.0

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 21A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2516 DE 26-03-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.